Cited by 951Schizophrenia research and treatmentCardiac Health and Mental HealthDiabetes, Cardiovascular Risks, and Lipoproteins

The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index.

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

De Hert, M., Dekker, J.M., Wood, D., Kahl, K.G., Holt, R.I.G., Möller, H.-J.·2009·European Psychiatry

DOI 10.1016/j.eurpsy.2009.01.005

Open this paper in CoChat — free account

Abstract

People with severe mental illnesses, such as schizophrenia, depression or bipolar disorder, have worse physical health and reduced life expectancy compared to the general population. The excess cardiovascular mortality associated with schizophrenia and bipolar disorder is attributed in part to an increased risk of the modifiable coronary heart disease risk factors; obesity, smoking, diabetes, hypertension and dyslipidaemia. Antipsychotic medication and possibly other psychotropic medication like antidepressants can induce weight gain or worsen other metabolic cardiovascular risk factors. Patients may have limited access to general healthcare with less opportunity for cardiovascular risk screening and prevention than would be expected in a non-psychiatric population. The European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC) published this statement with the aim of improving the care of patients suffering from severe mental illness. The intention is to initiate cooperation and shared care between the different healthcare professionals and to increase the awareness of psychiatrists and primary care physicians caring for patients with severe mental illness to screen and treat cardiovascular risk factors and diabetes.

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2009.01.005

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Obesity and physical activity: A review
Bensimhon, D., Kraus, W. E., & Donahue, M. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.005 · Cited by 122
Retracted
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“- Document téléchargé le 23/06/2011 par AS OF EUROPEAN diabetes [78,131].”
Background
Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
2007 Guidelines for the Management of Arterial Hypertension
Mancia, G., Backer, G. D., Dominiczak, A. F., Cífková, R., Fagard, R. H., Germanò, G., Grassi, G. M., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,870
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Self-citation
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Diagnosis and Classification of diabetes mellitus
Rossi, G. (2014) · Diapedia.org eBooks · doi:10.14496/dia..20 · Cited by 3,212
International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes
The International Expert Committee (2009) · Diabetes Care · doi:10.2337/dc09-9033 · Cited by 3,185
Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy.
Rozanski, A., Blumenthal, J. A., & Kaplan, J. (1999) · Circulation · doi:10.1161/01.cir.99.16.2192 · Cited by 2,846

Show all 152 references

Research works printed but not linked: 8

10.1176/ajp.2006.163.4.611 · DOI
Scheen, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
Correll, 2008, Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents, J Clin Psychiatry, 69, 26
Citrome, 2007, Risk-Benefit Analysis of Available Treatments for Schizophrenia, Psychiatric Times, 1, 27
2008, Clinical Practice Guidelines for the prevention and management of diabetes in Canada, Can J Diabetes, 32, S1
Casey, 2004, Antipsychotic-Induced Weight Gain and Metabolic Abnormalities: Implications for Increased Mortality in Patients With Schizophrenia, J Clin Psychiatry, 65, 4
Henderson, 2005, Schizophrenia and comorbid metabolic disorders, J Clin Psychiatry, 66, 11
Nicol, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32

Sorted by citations

Items 401–500 of 948

Priority actions for the non-communicable disease crisis
Humayun, Q., & Mirza, S. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61282-8 · Cited by 14
Preventive service use among people with and without serious mental illnesses.
Yarborough, B. J. H., Perrin, N. A., Stumbo, S. P., Muench, J., & Green, C. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2017.08.020 · Cited by 13
Chronic Illness Histories of Adults Entering Treatment for Co‐occurring Substance Abuse and Other Mental Health Disorders
Chesher, N. J., Bousman, C., Gale, M., Norman, S. B., Twamley, E. W., Heaton, R. K., Everall, I., & Judd, P. A. (2011) · American Journal on Addictions · doi:10.1111/j.1521-0391.2011.00196.x · Cited by 13
Metabolic syndrome and psychiatrists' choice of follow-up interventions in patients treated with atypical antipsychotics in Denmark and Sweden
Larsen, J. T., Fagerquist, M. V., Holdrup, M., Christensen, B., Sigalin, C., & Nilsson, P. M. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2010.486443 · Cited by 13
The association between primary care quality and health-care use, costs and outcomes for people with serious mental illness: a retrospective observational study
Jacobs, R., Aylott, L. M. E., Dare, C. R. J., Doran, T., Gilbody, S. M., Goddard, M. K., Gravelle, H. S. E., Gutacker, N., Kasteridis, P., Kendrick, T., et al. (2020) · Health Services and Delivery Research · doi:10.3310/hsdr08250 · Cited by 15
Senses of Touch: The Absence and Presence of Touch in Health Care Encounters of Patients with Mental Illness
Christensen, I. E., Risør, M. B., Grøn, L., & Reventlow, S. D. (2022) · Culture Medicine and Psychiatry · doi:10.1007/s11013-022-09770-9 · Cited by 13
Fasting or the short‐term consumption of a ketogenic diet protects against antipsychotic‐induced hyperglycaemia in mice
Shamshoum, H., Medak, K. D., McKie, G. L., Hahn, M., & Wright, D. C. (2022) · The Journal of Physiology · doi:10.1113/jp282922 · Cited by 13
Stress, psychische Erkrankungen und koronare Herzkrankheit
Lederbogen, F., & Ströhle, A. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3666-7 · Cited by 16
[Prevalence of metabolic syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB Study].
Gutiérrez-Rojas, L., Perea, J. R. A., Bernardo, M., Rojo, L., Mesa, F., & Martínez-Ortega, J. M. (2014) · PubMed · Cited by 13
Schizophrenia, antipsychotic drugs and cardiovascular risk: Descriptive study in primary care
Sánchez, M. C., Escurriola, M. F., Bergé, D., Boreu, Q. F., Martin, M., & Goday, A. (2015) · European Psychiatry · doi:10.1016/j.eurpsy.2014.12.010 · Cited by 13
Metabolic syndrome in patients attending psychiatric day centres: prevalence and associations
Gubbins, A., Lally, J., & McDonald, C. (2012) · The Psychiatrist · doi:10.1192/pb.bp.111.037374 · Cited by 13
Factors influencing cardiometabolic monitoring practices in an adult community mental health service
Millar, F., Sands, N., & Elsom, S. (2014) · International Journal of Mental Health Nursing · doi:10.1111/inm.12085 · Cited by 13
Excess mortality, mental illness and global burden of disease
Lawrence, D. M. (2014) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796014000742 · Cited by 12
Cultural diversity in physical diseases among patients with mental illnesses
Larsen, J. I., Andersen, U. A., Becker, T. M., Bickel, G. G., Bork, B., Cordes, J., Frasch, K., Jacobsen, B. A., Jensen, S. O. W., Kilian, R., et al. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867412463614 · Cited by 12
Effectiveness of a risk-minimization activity involving physician education on metabolic monitoring of patients receiving quetiapine
Brody, R. S., Liss, C. L., Wray, H., Iovin, R. C., Michaylira, C. Z., Muthutantri, A., Damstetter, P., Datto, C. J., & Jefferies, L. C. (2015) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000102 · Cited by 13
Sex Differences in the Association of HOMA-IR Index and BDNF in Han Chinese Patients With Chronic Schizophrenia
Yang, Y., Zhang, Y., Wang, J., Ning, X., Zhang, Y., Zhao, T., Zhong, Y., Liu, Z., Xia, L., Li, W., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.656230 · Cited by 13
Indoleamine 2,3-dioxygenase (IDO)-activity in Severe Psychiatric Disorders: A Systemic Review
Fellendorf, F. T., Bonkat, N., Dalkner, N., Schönthaler, E. M. D., Manchia, M., Fuchs, D., & Reininghaus, E. Z. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666220718155616 · Cited by 13
The long-term clinical benefit and effectiveness of switching to once-daily quetiapine extended release in patients with schizophrenia
Chue, P. S., MALLA, A. K., Bouchard, R.-H., Lessard, S., Ganesan, S., Stip, É., Johnson, S., Chen, E. Y. H., Ahn, Y. M., Kim, S., et al. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2012.762903 · Cited by 13
A long time coming – The creation of an evidence base for physical activity prescription to improve health outcomes in bipolar disorder
Goodrich, D. E., & Kilbourne, A. M. (2010) · Mental health and physical activity · doi:10.1016/j.mhpa.2010.01.001 · Cited by 12
Cardiovascular Health Literacy and Treatment Adherence in Persons with Serious Mental Illness
Rose, L. E., Sawyer, A. L., & Everett, A. S. (2014) · Issues in Mental Health Nursing · doi:10.3109/01612840.2013.843622 · Cited by 12
The risk of metabolic disorders in patients treated with asenapine or olanzapine: a study conducted on real-world data in Italy and Spain
Maina, G., & Ripellino, C. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2014.943732 · Cited by 12
Metabolic syndrome in patients with severe mental illness in Gorgan
Marjani, A., Kamkar, M., Sanagoo, A., Zargarani, F., & Jouybari, L. M. (2016) · Journal of Natural Science Biology and Medicine · doi:10.4103/0976-9668.175073 · Cited by 12
Are diabetes self-management programmes for the general diabetes population effective for people with severe mental illness?: a systematic review
Coxon, A., McBain, H. B., Pavlova, N. T., Rowlands, H., & Mulligan, K. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02779-7 · Cited by 12
Somatic Problems and Dual Disorder Patients
Binder, M. D., Vancampfort, D., & Detraux, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-45375-5_23 · Cited by 13
Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders
Nishiyama, M., Kimijima, M., Muto, T., & Kimura, K. (2011) · Environmental Health and Preventive Medicine · doi:10.1007/s12199-011-0250-x · Cited by 12
Cardiometabolic consequences of therapy for chronic schizophrenia using second-generation antipsychotic agents in a medicaid population: clinical and economic evaluation.
Ward, A., Quon, P., Abouzaid, S., Haber, N., Ahmed, S., & Kim, E. (2013) · Europe PMC (PubMed Central) · Cited by 12
Shorter Chain Triglycerides Are Negatively Associated with Symptom Improvement in Schizophrenia
Tkachev, A., Stekolshchikova, E., Anikanov, N., Zozulya, S., Barkhatova, A., Klyushnik, T., & Petrova, D. (2021) · Biomolecules · doi:10.3390/biom11050720 · Cited by 11
Identifying determinants of diabetes risk and outcomes for people with severe mental illness: a mixed-methods study
Lister, J., Han, L., Bellass, S., Taylor, J., Alderson, S. L., Doran, T., Gilbody, S. M., Hewitt, C. E., Holt, R. I. G., Jacobs, R., et al. (2021) · Health Services and Delivery Research · doi:10.3310/hsdr09100 · Cited by 11
Self-citation
Poor Adherence to Antipsychotic Medication in People with Schizophrenia: Diffusion, Consequences and Contributing Factors
Sacchetti, E., & Vita, A. (2013) · Springer eBooks · doi:10.1007/978-88-470-2679-7_1 · Cited by 11
Antipsychotic-Induced Dyslipidemia Treated with Omega 3 Fatty Acid Supplement in an 11-Year-Old Psychotic Child: A 1-Year Follow-up
Pisano, S., Gritti, A., Catone, G., & Pascotto, A. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0060 · Cited by 11
Psicosis, riesgo cardiovascular y mortalidad asociada: ¿vamos por el buen camino?
Sánchez, M. C., Escurriola, M. F., Bergé, D., Goday, A., & Callol, J. A. V. (2013) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2013.05.006 · Cited by 11
Adherencia terapéutica y control de los factores de riesgo cardiovasculares en usuarios de atención primaria
Veliz-Rojas, L. H., Mendoza-Parra, S., & Barriga, O. A. (2015) · Enfermería Universitaria · doi:10.1016/j.reu.2015.05.003 · Cited by 11
Kardiale und metabolische Risikofaktoren bei schweren psychischen Erkrankungen
Lederbogen, F., Schwarz, P. E. H., Häfner, S., Schweiger, U., Bohus, M., & Deuschle, M. (2015) · Der Nervenarzt · doi:10.1007/s00115-014-4232-2 · Cited by 13
Smoking Cessation in Long-Term Conditions: Is There “An Opportunity in Every Difficulty”?
Siddiqi, K., Dogar, O. F., & Siddiqi, N. (2013) · International Journal of Population Research · doi:10.1155/2013/251048 · Cited by 11
Cancer incidence in young and middle-aged people with schizophrenia: nationwide cohort study in Taiwan, 2000–2010
Chen, L., Hung, Y., Chen, Y., Yang, S., Pan, C. H., Chen, C., & Kuo, C. J. (2016) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796016000883 · Cited by 11
Mental health and behavioral weight loss: 24-month outcomes in Veterans
Janney, C. A., Masheb, R. M., Lutes, L. D., Holleman, R. G., Kim, H. M., Gillon, L., Damschroder, L. J., & Richardson, C. R. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.003 · Cited by 12
Coronary Heart Disease Risk in Patients with Schizophrenia: A Lebanese Cross-Sectional Study
Haddad, C., Hallit, S. R., Salameh, P., Assi, T. B., & Zoghbi, M. (2017) · Journal of Comorbidity · doi:10.15256/joc.2017.7.107 · Cited by 11
Estimation of the number of patient deaths recognized by a medical practitioner as caused by adverse events in hospitals in Japan
Fujita, S., Iida, S., Nagai, Y., Shimamori, Y., Koyano, K., Moriyama, Y., & Hasegawa, T. (2017) · Medicine · doi:10.1097/md.0000000000008128 · Cited by 11
The Physical Health of Individuals Receiving Antipsychotic Medication: A Qualitative Inquiry on Experiences and Needs
Cocoman, A. M., & Casey, M. (2018) · Issues in Mental Health Nursing · doi:10.1080/01612840.2017.1386744 · Cited by 11
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
Lafeuille, M., Tandon, N., Tiggelaar, S., Kamstra, R. L., Lefèbvre, P., Kim, E., Yue, Y., & Joshi, K. (2018) · Drugs - Real World Outcomes · doi:10.1007/s40801-018-0130-4 · Cited by 11
Weight change over two years in people prescribed olanzapine, quetiapine and risperidone in UK primary care: Cohort study in THIN, a UK primary care database
Osborn, D., Petersen, I., Beckley‐Hoelscher, N., Walters, K. R., Nazareth, I., & Hayes, J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118780011 · Cited by 11
Metabolic Syndrome Screening in People With Severe Mental Illness: Results From Two Spanish Community Mental Health Centers
Guijarro, S. F., García, C. M., Pomarol-Clotet, E., López, E. N. E., Martí, M. D. B., & Cuadra, M. A. R. (2020) · Journal of the American Psychiatric Nurses Association · doi:10.1177/1078390319826686 · Cited by 9
Diabetes: increasing the knowledge base of mental health nurses
Hemingway, S., Trotter, F., Stephenson, J. R., & Holdich, P. (2013) · British Journal of Nursing · doi:10.12968/bjon.2013.22.17.991 · Cited by 11
Double jeopardy: diabetes and severe mental illness. Addressing the special needs of this vulnerable group
Blanchard, E., & Samaras, K. (2014) · Diabetes Management · doi:10.2217/dmt.14.24 · Cited by 10
Early prediction of olanzapine-induced weight gain for schizophrenia patients
Lin, C., Lin, S., Huang, Y., Wang, F., & Huang, C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.058 · Cited by 12
Effectiveness of online cognitive behavioral interventions that include mindfulness for clinically-diagnosed anxiety and depressive disorders: A systematic review and meta-analysis
Kirk, M. A., Pirbaglou, M., Weerasekera, R., & Ritvo, P. (2022) · International Journal of Mental Health · doi:10.1080/00207411.2021.1959807 · Cited by 10
Prevalence of, and factors associated with, diabetes mellitus in people with severe mental illness attending a multidisciplinary, outpatient cardiometabolic health assessment service
Lambert, T., Middleton, T., Chen, R., & Sureshkumar, P. (2023) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2022-003055 · Cited by 10
Exploring the Economic Implications of a Group-Based Lifestyle Intervention for Middle-Aged Adults with Chronic Schizophrenia and Co-Morbid Type 2 Diabetes
Park, A. A. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000366 · Cited by 10
NHS Health Checks for people with mental ill-health 2013–2017: an observational study
Garriga, C., Robson, J. P., Coupland, C. A. C., & Hippisley‐Cox, J. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796020001006 · Cited by 10
Metabolic profile in first episode drug naïve patients with psychosis and its relation to cognitive functions and social cognition: a case control study
Sayed, S. E., Gomaa, S., Alhazmi, A., ElKalla, I., & Khalil, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-31829-9 · Cited by 11
QTc Prolongation in Patients Acutely Admitted to Hospital for Psychosis and Treated with Second Generation Antipsychotics
Johnsen, E., Aanesen, K., Sriskandarajah, S., Kroken, R. A., Løberg, E., & Jørgensen, H. A. (2013) · Schizophrenia Research and Treatment · doi:10.1155/2013/375020 · Cited by 10
Psychiatric Disorders Impacting Critical Illness
Struble, L. M., Sullivan, B. J., & Hartman, L. S. (2013) · Critical Care Nursing Clinics of North America · doi:10.1016/j.ccell.2013.10.002 · Cited by 11
Efectividad de un proyecto de colaboración entre atención primaria y salud mental para mejorar el registro de factores de riesgo cardiovascular en pacientes con psicosis
Cabrera, L. V., Martin, M., & Martín‐Lopez, L. M. (2013) · Atención Primaria · doi:10.1016/j.aprim.2012.12.008 · Cited by 10
Efficacy and safety of aripiprazole once-monthly in obese and nonobese patients with schizophrenia: a post hoc analysis
Binder, M. D., Eramo, A., Landsberg, W., Kostic, D., Tsai, L.-F., & Baker, R. A. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s80479 · Cited by 10
Mortality Rates in Users of Typical and Atypical Antipsychotics: A Database Study in Poland
Zagożdżon, P., Goyke, B., & Wrotkowska, M. (2016) · Drugs - Real World Outcomes · doi:10.1007/s40801-016-0084-3 · Cited by 10
Financial incentives improve recognition but not treatment of cardiovascular risk factors in severe mental illness
Wilson, C. L., Rhodes, K. M., & Payne, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179392 · Cited by 10
Prevalence of severe cardiovascular disease in patients with schizophrenia
Marche, J.-C., Bannay, A., Baillot, S., Masson, V. D., Leveque, P., Schmitt, C., Laprévote, V., Schwan, R., & Dobre, D. (2021) · L Encéphale · doi:10.1016/j.encep.2021.02.008 · Cited by 10
Quality of clinical management of cardiometabolic risk factors in patients with severe mental illness in a specialist mental health care setting
Ringen, P. A., Lund-Stenvold, E. H., Andreassen, O. A., Gaarden, T. L., Hartberg, C. B., Johnsen, E., Myklatun, S., Osnes, K., Sørensen, K., Sørensen, K., et al. (2022) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2022.2039288 · Cited by 10
Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study
Johnsen, E., Gjestad, R., Kroken, R. A., Mellesdal, L., Løberg, E., & Jørgensen, H. A. (2010) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2010.522729 · Cited by 10
Síndrome metabólico y trastorno afectivo bipolar: una revisión de la literatura
López‐Jaramillo, C., Mejía, A. C., Velásquez, A. H., Palacio, T. F. R., & Zuluaga, J. O. (2013) · Revista Colombiana de Psiquiatría · doi:10.1016/s0034-7450(13)70021-0 · Cited by 10
Aripiprazole in patients with bipolar mania and beyond: an update of practical guidance
Goodwin, G. M., Abbar, M., Schlaepfer, T. E., Grunze, H., Licht, R. W., Bellivier, F., Fountoulakis, K. Ν., Altamura, A. C., Pitchot, W., Ågren, H., et al. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2011.628380 · Cited by 10
Cardiovascular disease and diabetes in people with severe mental illness : causes, consequences and pragmatic management : review
Holt, R. I. G. (2012) · The South African journal of diabetes & vascular disease · Cited by 10
Self-citation
An exploratory investigation of sexual health screening in the first 12 weeks of case management in populations with severe mental illness
Corbett, R., Elsom, S., Sands, N., & Prematunga, R. K. (2016) · International Journal of Mental Health Nursing · doi:10.1111/inm.12257 · Cited by 10
Care Burden for Mental Illness Patients, Attitude toward Mental Illness and Psychiatric Nursing Competency in Non-psychiatric Nurses
Jang, M. Y., & Shin, S. H. (2017) · Journal of Korean Academy of Psychiatric and Mental Health Nursing · doi:10.12934/jkpmhn.2017.26.1.55 · Cited by 12
Mental and self-rated health of bakery workers in Lebanon: A national study
Habib, R. R., El-Haddad, N. W., Elzein, K., & Hojeij, S. (2020) · SAGE Open Medicine · doi:10.1177/2050312120962345 · Cited by 10
Possible impact of ADRB3 Trp64Arg polymorphism on BMI in patients with schizophrenia
Sasayama, D., Hori, H., Teraishi, T., Hattori, K., Ota, M., Tatsumi, M., Higuchi, T., Amano, N., & Kunugi, H. (2012) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2012.05.007 · Cited by 10
Diabetes treatment for persons with severe mental illness: A registry-based cohort study to explore medication treatment differences for persons with type 2 diabetes with and without severe mental illness
Bakkedal, C., Persson, F., Kriegbaum, M., Andersen, J. S., Grand, M. K., Mohr, G. H., Lind, B., Andersen, C. L., Christensen, M., Siersma, V., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287017 · Cited by 9
Home-based Intervention with Semaglutide Treatment of Neuroleptic-Related Prediabetes (HISTORI): protocol describing a prospective, randomised, placebo controlled and double-blinded multicentre trial
Ganeshalingam, A. A., Uhrenholt, N. G., Arnfred, S., Gæde, P., Bilenberg, N., & Frystyk, J. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-077173 · Cited by 10
The magnitude of undiagnosed diabetes and Hypertension among adult psychiatric patients receiving antipsychotic treatment
Hirigo, A. T., & Teshome, T. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00588-2 · Cited by 9
The DIAMONDS intervention to support self-management of type 2 diabetes in people with severe mental illness: Study protocol for a single-group feasibility study
Brown, J. V. E., Ajjan, R., Alderson, S. L., Boehnke, J. R., Carswell, C., Doherty, P., Double, K., Gilbody, S. M., Hadjiconstantinou, M., Hewitt, C. E., et al. (2022) · SSM - Mental Health · doi:10.1016/j.ssmmh.2022.100086 · Cited by 10
Self-citation
Clinical and Economic Profile of Homeless Young Adults with Stroke in the United States, 2002-2017
Khan, S. U., Yedlapati, S. H., Khan, M. Z., Virani, S. S., Blaha, M. J., Sharma, G. V., Jordan, J. E., Kash, B. A., Vahidy, F., Arshad, A., et al. (2022) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2022.101190 · Cited by 9
The 3rd Schizophrenia International Research Society Conference, 14–18 April 2012, Florence, Italy: Summaries of oral sessions
Abbs, B., Achalia, R. M., Adelufosi, A. O., Aktener, A. Y., Beveridge, N. J., Bhakta, S. G., Blackman, R. K., Bora, E., Byun, M. S., Cabanis, M., et al. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.07.024 · Cited by 8
Cardiovascular Disease and Severe Mental Illness
Holt, R. I. G. (2014) · Key issues in mental health (Online)/Key issues in mental health (Print) · doi:10.1159/000365531 · Cited by 9
Self-citation
Reducing cardiovascular risk factors in non-selected outpatients with schizophrenia
Hansen, M. V., Hjorth, P., Kristiansen, C. B., Vandborg, K., Gustafsson, L. N., & Munk‐Jørgensen, P. (2016) · International Journal of Social Psychiatry · doi:10.1177/0020764016636277 · Cited by 9
Experimental drugs for bipolar psychosis
Fornaro, M., Nardi, A. E., Berardis, D. D., & Carta, M. G. (2016) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2016.1256390 · Cited by 9
Framingham coronary score in individuals with symptoms or diagnoses of mental disorders: A review and meta-analysis
Rigal, A., Colle, R., Asmar, K. E., Elie-Lefebvre, C., Falissard, B., Becquemont, L., Verstuyft, C., & Corruble, E. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.02.035 · Cited by 10
Improving physical healthcare provided to psychiatric inpatients at an acute mental health trust
Hassan, S., Byravan, S., & Al-Zubaidi, D. H. (2019) · BMJ Open Quality · doi:10.1136/bmjoq-2018-000537 · Cited by 9
Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study
Tous‐Espelosin, M., de Azúa, S. R., Iriarte‐Yoller, N., Aguirre-Betolaza, A. M., Sánchez, P., Corres, P., Arratibel-Imaz, I., Sampedro, A., Peña, J., & Maldonado‐Martín, S. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113580 · Cited by 10
Applicability of somatic monitoring instructions in clinical practice guidelines on antipsychotic drug use
Brouwer, J., Hengel, E. O., Risselada, A., van Roon, E. N., & Mulder, H. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03162-w · Cited by 9
Appraisal of patient-level health economic models of severe mental illness: systematic review
Altunkaya, J., Lee, J.-S., Tsiachristas, A., Waite, F., Freeman, D. H., & Leal, J. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2021.121 · Cited by 10
Investigating the Role of Leukocyte Telomere Length in Treatment-Resistant Depression and in Response to Electroconvulsive Therapy
Pisanu, C., Vitali, E., Meloni, A., Congiu, D., Severino, G., Ardau, R., Chillotti, C., Trabucchi, L., Bortolomasi, M., Gennarelli, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111100 · Cited by 11
Schizophrenia: A major risk factor for cardiovascular disease
Ohlsen, R. I., & Gaughran, F. (2011) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2011.6.5.228 · Cited by 9
Association between psychosocial distress with cardio metabolic risk factors and liver enzymes in a nationally-representative sample of Iranian children and adolescents: the CASPIAN-III study
Qorbani, M., Kelishadi, R., Taheri, E., Motlagh, M. E., Arzaghi, S. M., Ardalan, G., Chinian, M., Mahmoudarabi, M., Rezapoor, A., Asayesh, H., et al. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-44 · Cited by 9
Prior psychiatric hospitalization is associated with excess mortality in patients hospitalized with non-cardiac chest pain: a data linkage study based on the full Scottish population (1991-2006)
Gillies, M., Jhund, P. S., MacTeague, K., MacIntyre, P., Allardyce, J., Batty, G. D., & Macintyre, K. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr401 · Cited by 9
Prevalence and correlates of heart disease among adults in Singapore
Picco, L., Subramaniam, M., Abdin, E., Vaingankar, J. A., & Chong, S. A. (2015) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.12.005 · Cited by 9
Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers
Vandenberghe, F., Saigí-Morgui, N., Delacrétaz, A., Quteineh, L., Crettol, S., Ansermot, N., Gholam‐Rezaee, M., von Gunten, A., Conus, P., & Eap, C. B. (2016) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000249 · Cited by 9
Temporal trends in cardiovascular disease risk factor profiles in a population-based schizophrenia sample: a repeat cross-sectional study
Chiu, M., Rahman, F., Vigod, S. N., Wilton, A. S., & Kurdyak, P. A. (2017) · Journal of Epidemiology & Community Health · doi:10.1136/jech-2017-209565 · Cited by 9
Violencia de pareja y depresión en mujeres que trabajan en una institución de salud de México
Guzmán-Rodríguez, C., Cupul‐Uicab, L. A., Borges, G. L. G., Salazar-Martínez, E., Salmerón, J., & Reynales-Shigematsu, L. M. (2019) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2019.09.005 · Cited by 13
Outreach visits by clinical pharmacists improve screening for the metabolic syndrome among mentally ill patients
Kjeldsen, L. J., Hansen, P. S., Kristensen, A. M. F., Christensen, A., Sørensen, C. H., & NIELSEN, B. L. (2012) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2012.732115 · Cited by 8
Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study
Mitchell, A. J., Vancampfort, D., Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., & Binder, M. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210674 · Cited by 8
Knowledge of Prevention Measures and Information About Coronavirus in Romanian Male Patients with Severe Mental Illness and Severe Alcohol Use Disorder
Matei, V. P., Pavel, A. N., Giurgiuca, A., Roşca, A., Sofia, A. D., Dutu, I., & Tudose, C. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s278471 · Cited by 9
Perinatal Mental Illness and Risk of Incident Autoimmune Disease: A Population-Based Propensity-Score Matched Cohort Study
Brown, H. K., Wilton, A. S., Liu, N., Ray, J. G., Dennis, C., & Vigod, S. N. (2021) · Clinical Epidemiology · doi:10.2147/clep.s344567 · Cited by 9
Association between brain similarity to severe mental illnesses and comorbid cerebral, physical, and cognitive impairments
Ma, Y., Kvarta, M. D., Adhikari, B. M., Chiappelli, J., Du, X. M., van der Vaart, A. D., Goldwaser, E. L., Bruce, H. A., Hatch, K. S., Gao, S., et al. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119786 · Cited by 8
30-year cardiovascular disease risk for young adults with serious mental illness
Miley, K. M., Hooker, S. A., Crain, A. L., O’Connor, P. J., Haapala, J. L., Bond, D. J., & Rossom, R. C. (2023) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2023.10.015 · Cited by 8
Who is at risk for weight gain after weight‐gain associated treatment with antipsychotics, antidepressants, and mood stabilizers: A machine learning approach
Eder, J., Glocker, C., Barton, B. B., Sarisik, E., Popovic, D., Lämmermann, J., Knaf, A., Beqiri‐Zagler, A., Engl, K., Rihs, L., et al. (2024) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13684 · Cited by 8
Frequency and clinical correlates of bipolar features in acute coronary syndrome patients
Pini, S., Abelli, M., Gesi, C., Lari, L., Cardini, A., Paolo, L. D., Felice, F., Stefano, R. D., Mazzotta, G., Oligeri, C., et al. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.06.007 · Cited by 8
Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine
Kemp, D. E., Binder, M. D., Rahman, Z. U., Fyans, P., Eudicone, J. M., Marler, S. V., Baker, R. A., & Carlson, B. X. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.054 · Cited by 8
Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs
Delacrétaz, A., Zdralovic, A., Vandenberghe, F., Saigí-Morgui, N., Glatard, A., Quteineh, L., Gholam‐Rezaee, M., Raffoul, W., Applegate, L. A., Jafari, P., et al. (2017) · Gene · doi:10.1016/j.gene.2017.07.005 · Cited by 8
Bidirectional association between depressive symptoms and carotid atherosclerosis in community-based older adults in China
Guan, S., Fang, X., Gu, X., Yang, H., Tang, Z., Liu, B., & Zhang, Z. (2019) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2019.02.013 · Cited by 8
Improving Interprofessional Attitudes Towards Mental and Physical Comorbidities: The Effectiveness of High Fidelity Simulation Training Versus Roleplay
Saadi, A., Uddin, T., Fisher, M. E., Cross, S., & Attoe, C. (2021) · Clinical Simulation in Nursing · doi:10.1016/j.ecns.2021.01.012 · Cited by 8

Authors: De Hert, M., Dekker, J. M., Wood, D., Kahl, K. G., Holt, R. I. G., & Möller, H.-J.
Affiliations: KU Leuven (BE)
Imperial College London (GB)
Medizinische Hochschule Hannover (DE)
University of Southampton (GB)
Ludwig-Maximilians-Universität München (DE)
ORCID: Wood, D.
Holt, R.I.G.
Venue: European Psychiatry
Publisher: Cambridge University Press (CUP)
Published: 2009-09
Volume: 24
Issue: 6
Pages: 412-424
ISSN: 0924-9338 (ISSN-L)
1778-3585
DOI: 10.1016/j.eurpsy.2009.01.005
OpenAlex: W2154493342
Cited by: 951
References: 152
Citations by year: 2026: 27 · 2025: 32 · 2024: 37 · 2023: 61 · 2022: 42 · 2021: 64 · 2020: 59 · 2019: 62 · 2018: 46 · 2017: 44 · 2016: 69 · 2015: 63 · 2014: 71 · 2013: 66 · 2012: 65
FWCI: 42.54
Type: journal article
Language: en
Open access: closed
Licence: www.cambridge.org/core/terms (unspecified, 3880 d)
Locations: European Psychiatry (publishedVersion)
PubMed (publishedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
Lirias (submittedVersion)
Pure Amsterdam UMC (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: Bristol-Myers Squibb
European Society of Cardiology
European Association for the Study of Diabetes
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords: severe mental illness, cardiovascular disease, diabetes mellitus, schizophrenia, bipolar disorder, depression, cardiovascular risk factors, antipsychotic-induced weight gain, psychotropic drugs, cardiovascular risk screening, cardiovascular disease prevention, shared care, life expectancy, coronary artery disease
MeSH terms: Bipolar Disorder, Cardiovascular Diseases, Cause of Death, Cross-Sectional Studies, Major Depressive Disorder, Diabetes Mellitus, Follow-Up Studies, Humans, Mass Screening, Obesity, Psychotic Disorders, Psychotropic Drugs, Risk Factors, Schizophrenia, Societies, Medical, Comorbidity, Practice Guidelines as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks